Ballicules.com

Penicillamine

CUPRIMINE

What it isChelator of copper and heavy metals; Wilson disease, cystinuria and lead poisoning.

Why this oneIt is the long-established oral treatment for Wilson disease and reduces cystine stone formation.

What limits itParadoxical neurological worsening early in Wilson disease. Myelosuppression, proteinuria and drug-induced autoimmunity; pyridoxine is co-given.

FDA label

BOXED WARNING Serious, potentially fatal toxicity; use only under close, continuous physician supervision and warn patients to report toxicity promptly.
FDA dosingPopulationStartTargetMax
Wilson's diseaseadult250 mg QD (if intolerant) up to 750 mg-1.5 g/day0.75-1.5 g/day2 g/day
Cystinuriaadult250 mg QD, increase gradually2 g/day QID4 g/day
Cystinuriapediatric30 mg/kg/day divided QID
Rheumatoid arthritisadult125-250 mg QD500-750 mg/day~1.5 g/day

Titration RA: increase by 125-250 mg/day at 1-3 month intervals.

Renal Undefined

Hepatic Undefined

Doses <=500 mg/day may be given once daily; >500 mg/day must be divided.

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Pregnancy Category D.

Lactation Do not nurse during penicillamine therapy.

⚠ BOXED WARNING

Cost, est. cash$10–$500/month

Generic entry2019

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilitySerious infection, cytopenias, hepatic injury and malignancy risk require laboratory and clinical monitoring.

Mechanism of action: Penicillamine ballicule

Penicillamine ballicule: receptor binding, kinetics and half-life diagram

Open Penicillamine in the interactive console ↗